H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.7% of adults in Augusta have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Census population 202,081. Georgia Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Augusta clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Augusta storefront.
Growth Factor Therapy for Tissue Repair in Augusta, GA for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 25.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 16.7% of adults in Augusta have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JJ-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JJ reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Augusta is 16.7% or not. PLACES is planning data. The LCD is the claim.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 16.7% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 16.7% of adults — 4.7 points above the U.S. 12% figure. Obesity is 36.1%; arthritis is 25.7%. That is place-level BRFSS modeling, not a clinic census and not a Augusta trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Georgia.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Georgia compliance risk.
If you operate in Georgia and another MAC state, say it on the first call. JJ will not port 1:1. We would rather split utilization than watch a sister clinic copy Augusta tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Augusta, GA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Augusta is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Augusta — 4.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Georgia Part B wound biologics follow this contractor (siblings: AL, TN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Augusta. Useful for joint-program math; still needs a diagnosis and privileging.
No Augusta storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.